Relbiplat 50mg Injection
Marketer
Relic Biotechnology Pvt Ltd
Salt Composition
Oxaliplatin (50mg)
Overview Relbiplat 50mg Injection
Oxaliplatin 50mg injection treats colorectal cancer by inhibiting cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Adhere strictly to your doctor's instructions; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinue only under medical supervision. Common side effects include nausea, fatigue, vomiting, and diarrhea. This medication can reduce blood cell counts (red and white), increasing infection risk. Serious allergic reactions (sore mouth/lips, rash, itching, breathing difficulties) necessitate immediate medical attention. Regular blood tests monitor blood cell levels, along with heart, liver, and uric acid levels. Inform your doctor of pre-existing heart, liver, or kidney conditions, or any concurrent infection treatments. Interactions with other medications are possible; disclose all medications to your healthcare provider. Use is contraindicated during pregnancy and breastfeeding. Male infertility is a potential side effect; sperm freezing should be discussed with your doctor. Driving is discouraged due to potential dizziness.
Uses of Relbiplat 50mg Injection
Colorectal cancer
Major Benefits of Relbiplat 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Relbiplat 50mg Injection:
- Nausea
- Fatigue
- Anemia (low number of red blood cells)
- Vomiting
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Low blood platelets
- Increased liver enzymes
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Stomatitis (Inflammation of the mouth)
How to use Relbiplat 50mg Injection:
Administering this medication will be handled by your physician or their assigned nurse; self-medication is strongly discouraged.
How Relbiplat 50mg Injection works:
Relbiplat 50mg Injection is a cancer treatment agent. Its mechanism of action involves disrupting the genetic blueprint (DNA and RNA) of cancerous cells, thus halting their proliferation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Relbiplat 50mg Injection lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Relbiplat 50mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might consider its use if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administration of Relbiplat 50mg Injection is contraindicated while breastfeeding due to potential infant toxicity.
DrivingUNSAFE
Driving ability may be impaired by Relbiplat 50mg Injection, which can induce side effects. Oxaliplatin therapy similarly elevates the risk of dizziness, nausea, vomiting, and other neurological issues impacting ambulation, potentially compromising driving safety.
KidneyCAUTION
Relbiplat 50mg Injection requires careful administration in individuals with severe renal impairment, potentially necessitating dosage modification. Consult your physician for guidance. Data on Relbiplat 50mg Injection use in such patients is limited. Dosage alteration is not advised for those with mild or moderate kidney disease.
LiverCAUTION
Patients with hepatic impairment should use Relbiplat 50mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Relbiplat 50mg Injection :
Omitting a scheduled dose of Relbiplat 50mg Injection necessitates contacting your physician.
Facts to Know About Relbiplat 50mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Platinum Equivalents |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Actions | Platinum-based anticancer agents |
3,018 People bought this recently